NASDAQ:AVGRAvinger Stock Price, Forecast & News

$0.33

+0.01 (+2.98 %)

(As of 05/28/2020 01:22 PM ET)

Add

Compare

Today's Range

$0.32

Now: $0.33▼

$0.34

50-Day Range

$0.28

MA: $0.36▼

$0.51

52-Week Range

$0.24

Now: $0.33▼

$5.70

Volume19,223 shs

Average Volume3.39 million shs

Market Capitalization$10.49 million

P/E RatioN/A

Dividend YieldN/A

Beta1.13

Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.

Beat the Market (BTM) Rank^™

3.3 Analyst's Opinion

Consensus Rating
Avinger has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $1.40, Avinger has a potential upside of 318.9% from its current price of $0.33.
Amount of Analyst Coverage
Avinger has only been the subject of 2 research reports in the past 90 days.

2.7 Community Rank

Outperform Votes
Avinger has received 362 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Avinger has received 320 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Avinger has received 53.08% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote “Outperform” if you believe AVGR will outperform the S&P 500 over the long term. Vote “Underperform” if you believe AVGR will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Avinger does not currently pay a dividend.
Dividend Growth
Avinger does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Avinger insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.51% of the stock of Avinger is held by insiders.
Percentage Held by Institutions
Only 7.34% of the stock of Avinger is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Avinger are expected to grow in the coming year, from ($0.98) to ($0.46) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Avinger is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Avinger is -0.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Avinger has a P/B Ratio of 2.39. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.32 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:AVGR

Previous Symbol

CUSIPN/A

CIK1506928

Webwww.avinger.com

Phone650-241-7900

Debt

Debt-to-Equity Ratio0.89

Current Ratio1.11

Quick Ratio0.85

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual Sales$9.13 million

Price / Sales1.15

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.14 per share

Price / Book2.39

Profitability

EPS (Most Recent Fiscal Year)($3.18)

Net Income$-19,450,000.00

Net Margins-211.96%

Return on Equity-270.15%

Return on Assets-78.28%

Miscellaneous

EmployeesN/A

Outstanding Shares31,340,000

Market Cap$10.49 million

Next Earnings Date7/29/2020 (Estimated)

OptionableNot Optionable

Receive AVGR News and Ratings via Email

Sign-up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter.

Avinger (NASDAQ:AVGR) Frequently Asked Questions

How has Avinger's stock been impacted by COVID-19 (Coronavirus)?

Avinger's stock was trading at $0.43 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AVGR shares have decreased by 22.3% and is now trading at $0.3342. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Avinger?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Avinger.

When is Avinger's next earnings date?

Avinger is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for Avinger.

How were Avinger's earnings last quarter?

Avinger Inc (NASDAQ:AVGR) released its quarterly earnings data on Wednesday, May, 13th. The medical device company reported ($0.47) EPS for the quarter, missing analysts' consensus estimates of ($0.41) by $0.06. The medical device company earned $2.26 million during the quarter. Avinger had a negative return on equity of 270.15% and a negative net margin of 211.96%. View Avinger's earnings history.

When did Avinger's stock split? How did Avinger's stock split work?

Avinger shares reverse split on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.

What guidance has Avinger issued on next quarter's earnings?

Avinger issued an update on its first quarter 2020 After-Hours earnings guidance on Wednesday, April, 15th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.25-2.25 million, compared to the consensus revenue estimate of $2.56 million.

What price target have analysts set for AVGR?

2 equities research analysts have issued 1-year price objectives for Avinger's shares. Their forecasts range from $1.40 to $1.40. On average, they anticipate Avinger's share price to reach $1.40 in the next twelve months. This suggests a possible upside of 318.9% from the stock's current price. View analysts' price targets for Avinger.

Has Avinger been receiving favorable news coverage?

Press coverage about AVGR stock has been trending somewhat positive recently, according to InfoTrie. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Avinger earned a daily sentiment score of 1.0 on InfoTrie's scale. They also gave press coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View the latest news aboutAvinger.

Who are some of Avinger's key competitors?

Some companies that are related to Avinger include Neuronetics (STIM), Motus GI (MOTS), Sensus Healthcare (SRTS), Arch Therapeutics (ARTH), Neovasc (NVCN), Invo Bioscience (IVOB), Biostage (BSTG), DarioHealth (DRIO), Delcath Systems (DCTH), Atossa Genetics (ATOS), Interpace Diagnostics Group (IDXG), Titan Medical (TMDI), Endologix (ELGX), Dynatronics (DYNT) and Encision (ECIA). View all competitors.

What other stocks do shareholders of Avinger own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Avinger investors own include AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), Onconova Therapeutics (ONTX), Palatin Technologies (PTN), Biocept (BIOC), Micron Technology (MU), Rigel Pharmaceuticals (RIGL), Alibaba Group (BABA), Canopy Growth (CGC) and Genocea Biosciences (GNCA).

Who are Avinger's key executives?

Avinger's management team includes the following people:

Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 57)
Mr. Mark B. Weinswig, Chief Financial Officer (Age 46)
Mr. Himanshu N. Patel, Chief Technology Officer (Age 59)
Mr. Keith Schaefer, Chief Operating Officer
Mr. Philip R. Preuss, VP of Marketing & Bus. Operations (Age 41)

When did Avinger IPO?

(AVGR) raised $60 million in an initial public offering on Friday, January 30th 2015. The company issued 4,600,000 shares at a price of $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.

What is Avinger's stock symbol?

Avinger trades on the NASDAQ under the ticker symbol "AVGR."

Who are Avinger's major shareholders?

Avinger's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Perkins Capital Management Inc. (7.52%) and Sabby Management LLC (1.93%). View institutional ownership trends for Avinger.

Which institutional investors are buying Avinger stock?

AVGR stock was purchased by a variety of institutional investors in the last quarter, including Sabby Management LLC, and Perkins Capital Management Inc.. View insider buying and selling activity for Avinger.

How do I buy shares of Avinger?

Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Avinger's stock price today?

One share of AVGR stock can currently be purchased for approximately $0.33.

How big of a company is Avinger?

Avinger has a market capitalization of $10.47 million and generates $9.13 million in revenue each year. The medical device company earns $-19,450,000.00 in net income (profit) each year or ($3.18) on an earnings per share basis.

What is Avinger's official website?

The official website for Avinger is www.avinger.com.

How can I contact Avinger?

Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]

This page was last updated on 5/28/2020 by MarketBeat.com Staff